Ascendis Pharma A/S

ASND
$274.50 (+ $6.71 + 2.51%)
Last updated: 2026-07-04 02:42 UTC
ASND Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS04351P1012
CUSIP04351P101
Market Price274.5
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPS-4.51
Market Cap$12.8B
Book Value-3.35
Price to Book-62.311
Beta0.44
52w High229.94
52w Low118.03
Next Earnings DateN/A

Ascendis Pharma A/S trades under ticker ASND on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US04351P1012, CUSIP 04351P101.

Related researchASND stock priceASND share priceAscendis Pharma A/S stockAscendis Pharma A/S share price04351P101
About the Company
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Price History